title: Topiramate for alcoholism treatment: novel pharmacogenetic evidence for the journey to personalized medicine?
authors.affiliation: Section on Clinical Psychoneuroendocrinology and Neuropsychopharmacology, Laboratory of Clinical and Translational Studies,National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health,Bethesda, MD,USA.
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Leggio
authors.affiliation: Laboratory of Clinical and Translational Studies,National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health,Bethesda, MD,USA.
authors.forename: Melanie L
authors.initials: ML
authors.lastname: Schwandt
mesh_terms: D000428:Alcohol Drinking; D005260:Female; D005632:Fructose / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D010349:Patient Compliance / Q000523:psychology*; D010597:Pharmacogenetics; D018092:Kainic Acid Receptors / Q000235:genetics*; D000077236:Topiramate
chemical_list: D005632:Fructose; D018696:Neuroprotective Agents; D018092:Kainic Acid Receptors; D000077236:Topiramate